Login
$STTK
$4.66 +$0.01 (0.22%) Live

$STTK SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

–Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in Crohn’s disease; 12-week induction data expected in the first half of 2028 –

27 Oct 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G/A
11 Aug 2026 S-8
11 Aug 2026 8-K: Results of Operations and Financial Condition

–Phase 1 clinical trial results for SL-325 demonstrated a favorable safety profile, a potentially best-in-mechanism immunogenicity profile, and durable DR3 blockade of TL1A binding, potentially enabling prolonged dosing intervals –

11 Aug 2026 10-Q
17 Jul 2026 SCHEDULE 13D/A
07 Jul 2026 Form 4: Shukla Abhinav A., Chief Technical Officer

Received 410 shares by exercise or conversion ($1.46K) · Sold 410 shares ($2.87K) · Received 12,153 shares by exercise or conversion ($43.4K)

02 Jul 2026 Form 4: Shukla Abhinav A., Chief Technical Officer

Received 23,365 shares by exercise or conversion ($83.4K) · Sold 23,365 shares ($165K) · Received 100 shares by exercise or conversion ($357) · 1 more

02 Jul 2026 Form 4: Pandite Arundathy N., Chief Medical Officer

Sold 30,000 shares ($210K)

02 Jul 2026 144
01 Jul 2026 144
30 Jun 2026 144
17 Jun 2026 SCHEDULE 13G
15 Jun 2026 Form 4: Orbimed Advisors Llc, Director and 2 others

Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)

15 Jun 2026 SCHEDULE 13D/A
15 Jun 2026 Form 4: Ashiya Mona, Director

Acquired 1,250,000 Pre-Funded Warrants (right to buy) (Open Market Purchase)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support